The authors documented the fact that head and neck squamous cell carcinomas, which harbored p53 mutations (48 out of 110 patients), and that were treated with radiation therapy, had higher rates of loco-regional failure, once again strengthening the hypothesis that p53 mutations render a squamous carcinoma less responsive to radiotherapy. Here, TP53 is linked to head and neck squamous cell carcinoma.